Home / Research Library / BRAIN · Neuro-Signaling Research
BRAIN · Neuro-Signaling Research

DSIP (Delta Sleep-Inducing Peptide): A Research Overview

2026-06-08 · ~4 min read · For laboratory and educational use only

All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.

The short version
  • DSIP (delta sleep-inducing peptide) is a small molecule made of nine amino acids, first found in animals in the 1970s. Scientists study it as a lab tool, mostly to probe sleep and stress pathways in the brain.
  • Despite the name, the research does not clearly show it controls sleep. Most studies are old, small, in animals or cells, with mixed results that were not reliably repeated, so the evidence is weak and far from any firm conclusion about people.
  • No health authority has approved DSIP for any use. It is not an approved drug or supplement, and there is no established safe dose for humans or animals.
  • Reports of people using it for sleep or stress come from online communities, not controlled studies. These are personal anecdotes, not proof, and BioRegen does not make or back any such claims.
  • BioRegen sells DSIP strictly as a research chemical for laboratory and educational use only, not for human or veterinary use, and nothing about it is medical advice.

DSIP is short for delta sleep-inducing peptide. A peptide is a small chain of amino acids, which are the building blocks of proteins. This one is tiny. It has caught the interest of scientists who study the brain and how the body handles stress. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. Below is a plain summary of what researchers have looked at in published DSIP studies, mostly work tied to sleep and to the body's stress system.

What DSIP Is

DSIP is made of nine amino acids. Scientists first described it in the 1970s. They found it in blood drawn from the brains of animals that had been put into a sleep state. Researchers call it a neuromodulator, which means it seems to fine-tune brain signals rather than carry them directly the way a classic brain chemical does. Even with the word "sleep" in its name, scientists still do not agree on how, or even whether, DSIP shapes sleep. They are also still studying where it shows up in the body's nerve and hormone tissue. In practice it is treated only as a lab material, used in test-tube and animal studies.

Mechanism and What Research Explores

Scientists do not fully understand how DSIP works. In published studies, researchers have looked at whether it might help shape the body's stress response. Some of that work measured how brain cells fired in stressed rodents, in the parts of the brain tied to emotion and to stress control. Other studies looked at how cells make energy. They reported changes in how the tiny power plants inside brain cells, called mitochondria, used oxygen in rats given low-oxygen conditions. In all of this, DSIP is used as a tool to help scientists understand stress and brain signaling. It is not used as a treatment.

Research Stage and Limitations

DSIP research is still at an early stage. Most of it has been done in animals or in test tubes, often with few subjects and with study setups that differ from one another. That makes it hard to draw firm, wide conclusions from any single result. Some studies saw effects that changed with the amount used, and the results did not always agree from one study to the next. DSIP also breaks down fast in the body and does not last long, which makes it tricky to study. No careful study supports using it in people or animals. You may see people talking about DSIP online, but those are personal stories, not controlled science. BioRegen does not make or back up any claims based on them.

Laboratory Handling Notes

Like most research peptides, DSIP usually comes as a freeze-dried powder for lab use. Freeze-dried just means the water has been removed so the powder stays stable. Published lab methods describe some general good habits: keep the powder cold, keep it out of light, and avoid freezing and thawing it over and over. In the lab, researchers mix it with a fitting liquid only when they are about to use it. For a basic primer on how researchers mix and handle these solvents in a lab setting, see our guide on how to reconstitute peptides. None of this is guidance for giving the compound to people or animals.


Frequently Asked Questions

Is DSIP an approved sleep aid?

No. DSIP is not approved for use in people or animals anywhere, and it is sold only as a research compound. Even with the word "sleep" in its old name, scientists still have not settled whether it affects sleep at all.

What have researchers actually studied with DSIP?

Most published research has used animals or test-tube models. It has focused on how the brain handles stress signals and on how cells make energy. These are early, exploratory studies, not proof of anything in people.

How does DSIP compare to other research peptides?

DSIP is studied for different reasons than peptides tied to metabolism. To browse and compare research compounds by category, use our research finder tool.


Setting up a study? Start with our research guide and create a free account for 10% off your first order. You can also browse related compounds in our brain and neuro research category.

Selected Research References

Reference metadata sourced via PubMed.

This article is provided for laboratory and educational research purposes only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice. DSIP is sold and described strictly as a research chemical. BioRegen makes no claim that any compound treats, cures, or prevents any condition.

The evidence spectrum

The full research picture, clearly labeled

BioRegen reports the entire research landscape for this compound across four clearly separated tiers, strongest evidence first. Lower tiers, including community and anecdotal reports, are labeled as such and are not BioRegen claims.

Clinical Human trials

Human evidence for DSIP is limited and dated, drawn mostly from small studies conducted in the 1980s and 1990s rather than modern controlled trials. Investigators in that era reported exploratory work on parameters such as sleep quality, chronic pain, and withdrawal-related stress, but these reports involved small samples and varied methods, and findings were not consistently replicated. There is no large, contemporary, well-powered clinical trial program establishing efficacy, and no current authoritative consensus on a defined human use. BioRegen makes no claim that DSIP is safe or effective for any human purpose.

Preclinical Lab and animal

Preclinical research describes DSIP as an endogenous peptide first characterized in animal models, where investigators studied effects related to sleep regulation, stress responses, and tolerance to conditions such as hypoxia. Laboratory and animal work has also explored its interactions with neuroendocrine and antioxidant pathways, though mechanisms remain incompletely understood. This body of evidence sits at the laboratory and animal tier and does not, on its own, predict effects or safety in humans.

Anecdotal Community, unverified

Within biohacker communities and longevity-focused forums, individuals discuss DSIP largely in the context of sleep and stress, and it has received occasional mention in wellness-oriented media coverage. These discussions reflect personal accounts and informal community interest rather than structured study, and reported experiences vary widely. Such material should be read as unverified anecdotal commentary, not controlled data, and not a BioRegen claim.

Regulatory Approval status

DSIP is not approved by the FDA for any medical indication and is not an approved drug or dietary supplement. It is handled as a research chemical, and no regulatory body has cleared it for human use or established an approved dose. BioRegen supplies it strictly for laboratory and educational research, not for human use.

Tiers are evidence categories, not endorsements. Clinical and preclinical entries summarize third-party published research. Community and anecdotal entries are unverified reports discussed by others, not findings and not BioRegen claims. Nothing here is medical advice, and no compound is approved for human or veterinary use except where explicitly stated under Regulatory status.

In the catalog

Shop this research material

Related research

More peptide research to explore

Explore the research line

Browse the BioRegen catalog, or grab the free reference guide · create a free account for 10% off your first order.